McKinsey Health Institute: Proven Interventions Could Unlock $12.5 Trillion by 2050

A single, provocative number anchored a high-level panel at the United Nations General Assembly: $12.5 trillion in potential global economic gains by 2050 — not from new drugs or moonshot research, but from scaling interventions that already exist. Dr. Pooja Kumar of the McKinsey Health Institute laid out a data-driven case that health spending is economic investment, not just a budget line — a message aimed squarely at finance ministers, not just health officials.

• Scaling known, cheap health interventions to achievable levels could add $12.5 trillion to the global economy by 2050, with a 4-to-1 return on investment

• Life expectancy has risen, but the share of years spent in poor health hasn't budged in decades — adding sick years, not healthy ones

• A projected 10 million healthcare worker shortage by 2030 could be partially addressed by AI-enabled community health workers, a model already showing a 19-to-1 ROI

• The "Accra Reset" and declining global aid push countries toward domestic health sovereignty — making economic evidence for self-funded investment more urgent than ever

Why it matters: Governments worldwide celebrate rising life expectancy, but the underlying data tells a less flattering story — one with direct consequences for public budgets, workforce productivity, and how nations allocate scarce resources.